Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Steris's share price for the quarter that ended in Dec. 2023 was R$51. Steris's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 1,976 Mil. Therefore, Steris's market cap for the quarter that ended in Dec. 2023 was R$100,784 Mil.
Steris's quarterly market cap
increased
from Jun. 2023 (R$101,883 Mil) to Sep. 2023 (R$110,940 Mil) but then
declined
from Sep. 2023 (R$110,940 Mil) to Dec. 2023 (R$100,784 Mil).
Steris's annual market cap
increased
from Mar. 2021 (R$89,279 Mil) to Mar. 2022 (R$111,695 Mil) but then
declined
from Mar. 2022 (R$111,695 Mil) to Mar. 2023 (R$85,432 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Steris's Enterprise Value for Today is R$122,045 Mil.
Steris Market Cap Historical Data
The historical data trend for Steris's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Steris's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Steris's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Steris's Market Cap distribution charts can be found below:
* The bar in red indicates where Steris's Market Cap falls into.
Steris Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Steris's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Steris (BSP:S1TE34) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Steris Market Cap Related Terms
Thank you for viewing the detailed overview of Steris's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Steris is an Ireland-domiciled medical device company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its 2015 inversion to Ireland, the firm continues to derive roughly 70% of revenue from its U.S. operations, 10% from the United Kingdom, and the remaining 20% from other international regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSP:S1TE34 has been successfully added to your 